A detailed history of Townsend Asset Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Townsend Asset Management Corp holds 1,510 shares of AMGN stock, worth $502,528. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,510
Previous 1,430 5.59%
Holding current value
$502,528
Previous $406,000 16.01%
% of portfolio
0.18%
Previous 0.16%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$262.75 - $319.31 $21,020 - $25,544
80 Added 5.59%
1,510 $471,000
Q3 2023

Oct 20, 2023

BUY
$218.65 - $271.46 $4,810 - $5,972
22 Added 1.56%
1,430 $384,000
Q2 2023

Aug 07, 2023

SELL
$214.27 - $253.37 $79,922 - $94,507
-373 Reduced 20.94%
1,408 $312,000
Q1 2023

Apr 28, 2023

BUY
$225.79 - $275.2 $3,386 - $4,128
15 Added 0.85%
1,781 $430,000
Q4 2022

Feb 01, 2023

BUY
$229.03 - $291.01 $113,369 - $144,049
495 Added 38.95%
1,766 $463,000
Q1 2022

Apr 28, 2022

BUY
$219.27 - $242.57 $12,059 - $13,341
55 Added 4.52%
1,271 $307,000
Q4 2021

Feb 02, 2022

SELL
$198.88 - $227.6 $16,904 - $19,346
-85 Reduced 6.53%
1,216 $274,000
Q3 2021

Oct 21, 2021

SELL
$212.27 - $248.7 $15,283 - $17,906
-72 Reduced 5.24%
1,301 $277,000
Q2 2021

Jul 21, 2021

BUY
$233.58 - $259.14 $101,373 - $112,466
434 Added 46.22%
1,373 $335,000
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $66,573 - $77,580
-300 Reduced 24.21%
939 $234,000
Q4 2020

Feb 02, 2021

SELL
$216.38 - $257.67 $152,331 - $181,399
-704 Reduced 36.23%
1,239 $285,000
Q3 2020

Nov 02, 2020

SELL
$234.65 - $260.95 $5,162 - $5,740
-22 Reduced 1.12%
1,943 $494,000
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $1,582 - $1,941
8 Added 0.41%
1,965 $463,000
Q1 2020

May 07, 2020

BUY
$182.24 - $241.7 $1,093 - $1,450
6 Added 0.31%
1,957 $397,000
Q4 2019

Feb 06, 2020

BUY
$189.21 - $243.2 $369,148 - $474,483
1,951 New
1,951 $470,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $178B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Townsend Asset Management Corp Portfolio

Follow Townsend Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsend Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Townsend Asset Management Corp with notifications on news.